Defunct Company
Total Trials
12
As Lead Sponsor
8
As Collaborator
4
Total Enrollment
959
NCT00196599
Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults
Phase: Phase 2
Role: Collaborator
Start: Feb 28, 1999
Completion: Sep 30, 2004
NCT00002362
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 1999
Completion: Not specified
NCT00006208
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
Start: Aug 31, 2000
NCT00196612
Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART
Start: Apr 30, 2001
NCT00044135
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Start: Aug 31, 2002